Animalcare Group plc 2016 Year in Review

Supplying & Supporting

Veterinary Professionals throughout the UK

Full Annual Report 2016
;

Animalcare Group plc 2016 Year in Review

Focused on growing

its veterinary business

Full Annual Report 2016
;

Animalcare Group plc 2016 Year in Review

A sales and marketing

and product development company

Full Annual Report 2016
;

Financial Highlights

Revenue £m

+8.6%

at £14.7m

Underlying Operating Profit* £m

+2.6%

at £3.2m

Underlying Basic EPS Pence

+3.2%

at £13.0p

Dividend Per Share Pence

+6.6%

at £6.5p

*Underlying measures are before the effect of exceptional and other items as analysed in note 4 in the 2016 Annual Report.

Chairman's Statement

"Our strategy is on track to build a strong business and invest in product development and geographic expansion."

James Lambert Chairman
Download

Chief Executive's Review

"We have made great progress in the year with increased revenues, our development pipeline delivering, exports growing and exploring exciting opportunities to invest in innovation."

Iain Menneer Chief Executive Officer
Download

Chief Financial Officer's Review

"2016 was a strong year for the Group achieving underlying operating profit ahead of market expectations."

Chris Brewster Chief Financial Officer
Download

Strategic Objectives

1

Identify product candidates to maintain flow into and through development pipeline

Progress Against Strategic Themes

Product Development Pipeline

View our product development pipeline progress diagram to see the number of projects at each stage of the development pipeline. Progress is evident by the comparison to the number at the same time one year ago.

;

Strategic Objectives

2

Increase efforts to license in new pharmaceutical products

Progress Against Strategic Themes

Identifying Novel Pharmaceuticals to License

The investment in the technical and product development team has given us the extra capacity to actively search out novel, ideally patent protected, products to acquire or license. Several such opportunities have progressed to co-development projects or commercial negotiation during the period.

;

Strategic Objectives

3

Assess opportunities to innovate and strengthen Companion Animal Identification group

Progress Against Strategic Themes

Innovating in Companion Animal Identification

In preparation for the recent implementation of compulsory microchipping of dogs in England, Scotland and Wales, and the anticipated disruption to the market, we have reviewed our entire business model. As a result one project has started detailed planning in Q1 of the new financial year and another will be executed in Q3.

;

Strategic Objectives

4

Increase the sales of our current products outside the UK

Progress Against Strategic Themes

Increasing Sales Outside the UK

We have had a very successful first year implementing our planned expansion into more territories in Europe and the ROW, with revenues increased by 23%. Further progress will be made during the next two years as we gain the regulatory certification in each new territory.

;